fda news - Search News

FDA greenlights Regeneron’s Dupixent for treatment of COPD

US FDA approves Sanofi-Regeneron's Dupixent for 'smoker's lung'

The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a chronic lung disease, commonly known as "smoker's lung", the companies said on Friday.

Business Insider · 16h

Regeneron, Sanofi's Dupixent Get FDA Approval For Chronic Obstructive Pulmonary Disease Treatment

Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi (SNY), Friday announced that the U.S. Food and Drug Administration has approved

The Wall Street Journal on MSN · 16h

Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD

Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease.

Investopedia on MSN · 10h

Regeneron-Sanofi Drug Wins FDA Approval To Treat COPD

Key Takeaways Regeneron and Sanofi shares edged higher Friday after their drug to treat chronic obstructive pulmonary disease (COPD) received approval from the Food and Drug Administration (FDA).The drug,

FDA issues recall notices over 2 brands of pet food

AOL · 5h

FDA Alert: Dog Food Recall Over Salmonella, Listeria Fears — What Owners Must Do Now

Certain lots of Answers dog food and Darwin's Natural Pet Products, which includes dog and cat food, have been recalled after the FDA tested samples of the brand's pet food, which tested positive for salmonella and listeria. So far, no illnesses related to the recall have been reported, according to the FDA's press release.

USA TODAY on MSN · 1d

ANSWERS Pet Food recalled over salmonella, listeria concerns: What pet owners need to know

ANSWERS Pet Food is voluntarily recalling several of its products due to potential salmonella and listeria exposure, according to the FDA.

NBC Los Angeles · 1d

FDA issues recall notices over 2 brands of pet food due to salmonella and listeria risk

Answers Pet Food and Darwin’s Natural Pet Products, were found to have produced pet food that was contaminated with the bacteria salmonella and listeria, which can cause illness in pets that can then infect their owners.

Establishment Labs, FDA and Motiva

GlobalData on MSN · 14h

FDA approves Establishment Labs’ Motiva breast implants

The Motiva implants feature the patented SmoothSilk surface, engineered to improve biocompatibility and minimise inflammation.

Business Insider · 18h

Establishment Labs Jumps In Pre-market On FDA Approval Of Its Motiva Breast Implants

Shares of Establishment Labs Holdings Inc. (ESTA) were surging more than 21 percent in pre-market on Friday to $50.22, after its

MarketWatch · 20h

Establishment Labs Shares Surge Premarket on FDA Breast Implant Approval

Establishment Labs Holdings shares jumped nearly 30% in premarket trading Friday after the medical-technology company won Food and Drug Administration approval for its Motiva breast implants. After the closing bell Thursday,

FDA Lifts Clinical Hold On BMF-219

Reuters on MSN · 1d

US FDA lifts clinical hold on Biomea's diabetes trials

Biomea Fusion said on Thursday the U.S. Food and Drug Administration lifted a clinical hold on ongoing studies of its experimental drug for type 1 and 2 diabetes, sending its shares up 6.9%. The decision comes as a boon for the company as the regulator placed a hold on two trials of its lead drug,

Business Insider · 1d

FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials

We greatly appreciate FDA’s review of our data, and the swift resolution of the clinical trial hold. The in-depth review of the clinical data to date reconfirms our confidence in BMF-219 as a novel, first-in-class agent for the treatment of diabetes.

MarketWatch · 1d

Biomea Fusion: FDA Lifts Hold on Diabetes-Treatment Trials

Biomea Fusion said the Food and Drug Administration lifted its clinical hold on continuing clinical trials of the company's diabetes drug. The FDA in June put the biopharmaceutical company's trials on hold,

In a Victory for the Free Market, FDA Approves New Schizophrenia Drug

Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical ...

20h

FDA Approves New Kind of Drug for Schizophrenia

FRIDAY, Sept. 27, 2024 (HealthDay News) -- The first new type of medication in decades to help fight against schizophrenia ...

34m

AbbVie Submits BLA To FDA For Telisotuzumab Vedotin In Previously Treated Non-Small Cell Lung Cancer

AbbVie (ABBV) announced submission of a Biologics License Application or BLA to the U.S. Food and Drug Administration for accelerated ...

Food Safety News3h

FDA steps up import enforcement on certain cheese, seafood, coconut and more

The Food and Drug Administration continues using import alerts to enforce U.S. food safety regulations for food from foreign ...

US FDA Approves GE HealthCare's Diagnostic Drug for Heart Disease

(Reuters) - The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary ...

FDA approves 1st new drug for schizophrenia in more than 30 years

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...

22h

Bristol Myers wins US FDA approval for new type of schizophrenia drug

The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the ...

FDA approves new schizophrenia drug

The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday.

10hon MSNOpinion

Column: A federal appeals court hands the FDA a stupendous win in its battle against stem cell clinics

Just as it began to seem that the battle against pseudoscience in medicine was being lost, a federal appeals court in San ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Related topics